HEALTHY_LIVING_PHARMACY_L - Accounts

Company Registration No. 05098078 (England and Wales)
HEALTHY LIVING PHARMACY LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2021
PAGES FOR FILING WITH REGISTRAR
HEALTHY LIVING PHARMACY LIMITED
CONTENTS
Page
Balance sheet
1
Statement of changes in equity
Notes to the financial statements
2 - 6
HEALTHY LIVING PHARMACY LIMITED
BALANCE SHEET
AS AT
31 MARCH 2021
31 March 2021
- 1 -
2021
2020
Notes
£
£
£
£
Fixed assets
Tangible assets
5
120,339
124,776
Current assets
Stocks
48,107
47,370
Debtors
6
181,397
224,144
Cash at bank and in hand
67,441
13,446
296,945
284,960
Creditors: amounts falling due within one year
7
(144,757)
(172,570)
Net current assets
152,188
112,390
Total assets less current liabilities
272,527
237,166
Creditors: amounts falling due after more than one year
8
(49,963)
(54,710)
Net assets
222,564
182,456
Capital and reserves
Called up share capital
100
100
Profit and loss reserves
222,464
182,356
Total equity
222,564
182,456

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

For the financial year ended 31st March 2018 the company was entitled to exemption from audit under section 477 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the board of directors and authorised for issue on 24 September 2021 and are signed on its behalf by:
Mr D Leakey
Director
Company Registration No. 05098078
HEALTHY LIVING PHARMACY LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2021
- 2 -
1
Accounting policies
Company information

Healthy Living Pharmacy Limited is a private company limited by shares incorporated in England and Wales. The registered office is 40 Reevy Road West, Buttershaw, Bradford, West Yorkshire, BD6 3LX.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value. The principal accounting policies adopted are set out below.

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

1.2
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

1.3
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Land and buildings Freehold
2% on cost
Land and buildings Leasehold
20% on cost
Fixtures, fittings & equipment
25% on reducing balance
Computer equipment
25% on cost
Motor vehicles
25% on reducing balance

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

HEALTHY LIVING PHARMACY LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2021
1
Accounting policies
(Continued)
- 3 -
1.4
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

1.5
Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.

1.6
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.7
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

1.8
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

Changes in the fair value of derivatives that are designated and qualify as fair value hedges are recognised in profit or loss immediately, together with any changes in the fair value of the hedged asset or liability that are attributable to the hedged risk.

1.9
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax has not been provided in these accounts as the Directors consider the potential liability to be not material.

HEALTHY LIVING PHARMACY LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2021
1
Accounting policies
(Continued)
- 4 -
1.10
Government grants

Government grants are recognised at the fair value of the asset received or receivable when there is reasonable assurance that the grant conditions will be met and the grants will be received.

 

A grant that specifies performance conditions is recognised in income when the performance conditions are met. Where a grant does not specify performance conditions it is recognised in income when the proceeds are received or receivable. A grant received before the recognition criteria are satisfied is recognised as a liability.

1.11
Foreign exchange

Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.

2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

 

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

3
Employees

The average monthly number of persons (including directors) employed by the company during the year was 10 (2020 - 12).

2021
2020
Number
Number
Total
10
12
HEALTHY LIVING PHARMACY LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2021
- 5 -
4
Intangible fixed assets
Goodwill
£
Cost
At 1 April 2020 and 31 March 2021
440,000
Amortisation and impairment
At 1 April 2020 and 31 March 2021
440,000
Carrying amount
At 31 March 2021
-
0
At 31 March 2020
-
0
5
Tangible fixed assets
Land and buildings
Plant and machinery etc
Total
£
£
£
Cost
At 1 April 2020
178,617
88,458
267,075
Additions
-
0
38,579
38,579
Disposals
-
0
(55,364)
(55,364)
At 31 March 2021
178,617
71,673
250,290
Depreciation and impairment
At 1 April 2020
87,195
55,104
142,299
Depreciation charged in the year
2,536
11,284
13,820
Eliminated in respect of disposals
-
0
(26,168)
(26,168)
At 31 March 2021
89,731
40,220
129,951
Carrying amount
At 31 March 2021
88,886
31,453
120,339
At 31 March 2020
91,422
33,354
124,776
6
Debtors
2021
2020
Amounts falling due within one year:
£
£
Trade debtors
134,990
170,666
Other debtors
46,407
53,478
181,397
224,144
HEALTHY LIVING PHARMACY LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2021
- 6 -
7
Creditors: amounts falling due within one year
2021
2020
£
£
Bank loans
4,954
5,016
Trade creditors
106,589
131,948
Corporation tax
24,478
19,352
Other taxation and social security
403
874
Other creditors
8,333
15,380
144,757
172,570
8
Creditors: amounts falling due after more than one year
2021
2020
£
£
Bank loans and overdrafts
49,963
54,710
2021-03-312020-04-01false24 September 2021CCH SoftwareCCH Accounts Production 2021.200No description of principal activityMr M CheneryMr D Leakey050980782020-04-012021-03-31050980782021-03-31050980782020-03-3105098078core:LandBuildings2021-03-3105098078core:OtherPropertyPlantEquipment2021-03-3105098078core:LandBuildings2020-03-3105098078core:OtherPropertyPlantEquipment2020-03-3105098078core:CurrentFinancialInstrumentscore:WithinOneYear2021-03-3105098078core:CurrentFinancialInstrumentscore:WithinOneYear2020-03-3105098078core:CurrentFinancialInstruments2021-03-3105098078core:CurrentFinancialInstruments2020-03-3105098078core:Non-currentFinancialInstruments2021-03-3105098078core:Non-currentFinancialInstruments2020-03-3105098078core:ShareCapital2021-03-3105098078core:ShareCapital2020-03-3105098078core:RetainedEarningsAccumulatedLosses2021-03-3105098078core:RetainedEarningsAccumulatedLosses2020-03-3105098078bus:Director22020-04-012021-03-3105098078core:LandBuildingscore:OwnedOrFreeholdAssets2020-04-012021-03-3105098078core:LandBuildingscore:LongLeaseholdAssets2020-04-012021-03-3105098078core:FurnitureFittings2020-04-012021-03-3105098078core:ComputerEquipment2020-04-012021-03-3105098078core:MotorVehicles2020-04-012021-03-31050980782019-04-012020-03-3105098078core:NetGoodwill2020-03-3105098078core:NetGoodwill2021-03-3105098078core:NetGoodwill2020-03-3105098078core:LandBuildings2020-03-3105098078core:OtherPropertyPlantEquipment2020-03-31050980782020-03-3105098078core:LandBuildings2020-04-012021-03-3105098078core:OtherPropertyPlantEquipment2020-04-012021-03-3105098078core:WithinOneYear2021-03-3105098078core:WithinOneYear2020-03-3105098078bus:PrivateLimitedCompanyLtd2020-04-012021-03-3105098078bus:SmallCompaniesRegimeForAccounts2020-04-012021-03-3105098078bus:FRS1022020-04-012021-03-3105098078bus:AuditExemptWithAccountantsReport2020-04-012021-03-3105098078bus:Director12020-04-012021-03-3105098078bus:FullAccounts2020-04-012021-03-31xbrli:purexbrli:sharesiso4217:GBP